Opioid-Induced Constipation Treatment Market By Drug Type (Peripherally restricted ?-opioid receptor antagonists, Non-selective opioid antagonists, ? -opioid receptor antagonists, Locally acting chloride channel activators), By Formulation Type (Solids, Semi-solids, Liquids), By Administration (Oral, Parenteral), By Distribution Channel (Drugstore, Retail pharmacies, Hospital pharmacies) and Geography 

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Opioid Induced Constipation Treatment Market size is valued at USD 2911.97 million in 2021 and is expected to reach USD 4016.18 million by 2028, at a CAGR of 4.7% during the forecast period 2022-2028. Global Opioid Induced Constipation Treatment Market are the drugs used for its pain relieving properties in non-cancer and chronic pain. The adverse effects associated with the opioids are decreasing gastrointestinal tract’s motility, making patient’s strain, and making of solid discharges. Furthermore, long-term use of opioids cause harm to the sensory system, limits the release of endogenous opioids such as endorphins. Adults are most likely to prone to opioid-induced constipation owing to less immobility, poor diet, and fluid intake. The symptoms associated with the opioid-induced constipation are included dry and hard tools, leathery feeling, painful defecation, bulged abdomen, and loss of appetite. The Opioid-Induced Constipation Treatment Marketgrowing at a significant CAGR due to rise in the aging population using opioid analgesics for chronic pains. Increase in the illicit use of medications, prolonged usage of opioids in the treatment of pain, an increase in the prevalence of cancer is anticipated to boost the global Opioid-Induced Constipation Treatment Market. Furthermore, launching of newer drugs, growing FDA approvals, positive outcomes in clinical trials, and rise in the healthcare expenditure are expected to propel the Opioid-Induced Constipation Treatment Market over the forecast period. However, lack of awareness regarding opioid induced constipation in patients, the absence of treatment innovations, a high cost of newer pharmaceuticals, adverse effects, including nausea, a risk of heart problems and strokes associated with these drugs and unfavorable reimbursement policies expected to hamper the growth of the opioid-induced constipation treatment market. this report studies global Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Opioid Induced Constipation Treatment Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Opioid Induced Constipation Treatment Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). 

Global Opioid Induced Constipation Treatment Market Summary

Study Period

2023-29

Base Year

2022

CAGR

4.7%

Largest Market

North-America

Fastest Growing Market

Europe
Opioid Induced Constipation Treatment Market Dynamics

Opioid-induced constipation is becoming increasingly common. In 2013, the American Academy of Pain Medicine (AAPM) estimated that about 100 million individuals in the United States experienced opioid-induced constipation. Furthermore, the AAPM predicted that the number of instances would increase as the number of people using opioids increased. There is a rising awareness of the availability of a wide range of opioid medications. Patients will be more likely to use these medications to treat chronic pain as a result of this. The growing number of people suffering from opioid-induced constipation, particularly in North America, is expected to propel the total opioid-induced constipation treatment business forward. Because of the enormous number of persons who take opioid medicines, the regional market is expected to increase at a significant rate. This is due to the high prevalence of chronic pain-related diseases in this area.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Opioid Induced Constipation Treatment Market Segmentation

By Drug Type
  • Peripherally restricted ?-opioid receptor antagonists
  • Non-selective opioid antagonists
  • ? -opioid receptor antagonists
  • Locally acting chloride channel activators
By Formulation Type
  • Solids
  • Semi-solids
  • Liquids
Distribution Channel
  • Drugstore
  • Retail pharmacies
  • Hospital pharmacies

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1. Executive summary 2. Global Opioid-Induced Constipation Treatment Market Introduction 2.1. Global Opioid-Induced Constipation Treatment Market – Taxonomy 2.2. Global Opioid-Induced Constipation Treatment Market –Definitions 2.2.1. Type of vaccine 2.2.2. End User 3. Global Opioid-Induced Constipation Treatment Market Dynamics 3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global Opioid-Induced Constipation Treatment Market Dynamics – Factors Impact Analysis 3.6. Global Opioid-Induced Constipation Treatment Market – Regulations 3.6.1. U.S 3.6.2. Europe 3.6.3. Japan 3.6.4. China 3.7. Global Opioid-Induced Constipation Treatment Market – Product Innovations 4. Global Opioid-Induced Constipation Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 – 2024 4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market Oppurtunity Analysis 5. Global Opioid-Induced Constipation Treatment Market, By Drug Type, 2013 - 2017 and Forecast, 2018 - 2024 5.1. Peripherally restricted ?-opioid receptor antagonists 5.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 5.1.3. Market Opportunity Analysis 5.2. Non-selective opioid antagonists 5.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 5.2.3. Market Opportunity Analysis 5.3. ? -opioid receptor antagonists 5.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 5.3.3. Market Opportunity Analysis 6. Global Opioid-Induced Constipation Treatment Market Forecast, By Formulation Type, 2013 - 2017 and Forecast, 2018 - 2024 6.1. Solids 6.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 6.1.3. Market Opportunity Analysis 6.2. Semi-Solids 6.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 6.2.3. Market Opportunity Analysis 6.3. Liquids 6.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 6.3.3. Market Opportunity Analysis 7. Global Opioid-Induced Constipation Treatment Market Forecast, By Route of administration , 2013 - 2017 and Forecast, 2018 - 2024 7.1. Oral 7.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 7.1.3. Market Opportunity Analysis 7.2. Parenteral 7.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 7.2.3. Market Opportunity Analysis 8. Global Opioid-Induced Constipation Treatment Market Forecast, By Distribution Channel , 2013 - 2017 and Forecast, 2018 - 2024 8.1. Drug Stores 8.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 8.1.3. Market Opportunity Analysis 8.2. Retail Pharmacies 8.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 8.2.3. Market Opportunity Analysis 8.3. Hospital Pharmacies 8.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 8.3.3. Market Opportunity Analysis 9. Global Opioid-Induced Constipation Treatment Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024 9.1. North America 9.1.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 9.1.3. Market Opportunity Analysis 9.2. Europe 9.2.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 9.2.3. Market Opportunity Analysis 9.3. Asia-Pacific 9.3.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 9.3.3. Market Opportunity Analysis 9.4. Latin America 9.4.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 9.4.3. Market Opportunity Analysis 9.5. Middle East and Africa 9.5.1. Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn) 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 9.5.3. Market Opportunity Analysis 9.6. Global Opioid-Induced Constipation Treatment Market - Opportunity Analysis Index, By Type of Vaccine, End User, and Region, 2018 – 2024 10. North America Opioid-Induced Constipation Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 10.1.1. Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.1.1.1. Peripherally restricted ?-opioid receptor antagonists 10.1.1.2. Non-selective opioid antagonists 10.1.1.3. ? -opioid receptor antagonists 10.1.1.4. Locally acting chloride channel activators 10.1.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.1.2.1. Solids 10.1.2.2. Semi-Solids 10.1.2.3. Liquids 10.1.3. Route of administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.1.3.1. Oral 10.1.3.2. Parenteral 10.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.1.4.1. Drugstore 10.1.4.2. Retail pharmacies 10.1.4.3. Hospital pharmacies 10.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.1.5.1. U.S. 10.1.5.2. Canada 10.1.6. North America Opioid-Induced Constipation Treatment Market - Opportunity Analysis Index, By Drug Analysis, Formulation Type, Route of Administration, Distribution Channel, and Country, 2018 – 2024 10.1.7. North America Opioid-Induced Constipation Treatment Market Dynamics – Trends 11. Europe Opioid-Induced Constipation Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 11.1.1. Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.1.1.1. Peripherally restricted ?-opioid receptor antagonists 11.1.1.2. Non-selective opioid antagonists 11.1.1.3. ? -opioid receptor antagonists 11.1.1.4. Locally acting chloride channel activators 11.1.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.1.2.1. Solids 11.1.2.2. Semi-Solids 11.1.2.3. Liquids 11.1.3. Route of administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.1.3.1. Oral 11.1.3.2. Parenteral 11.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.1.4.1. Drugstore 11.1.4.2. Retail pharmacies 11.1.4.3. Hospital pharmacies 11.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.1.5.1. Germany 11.1.5.2. UK 11.1.5.3. France 11.1.5.4. Spain 11.1.5.5. Italy 11.1.5.6. Russia 11.1.5.7. Poland 11.1.5.8. Rest of Europe 11.1.6. Europe Opioid-Induced Constipation Treatment Market - Opportunity Analysis Index, By Drug Analysis, Formulation Type, Route of Administration, Distribution Channel, and Country, 2018 – 2024 11.1.7. Europe Opioid-Induced Constipation Treatment Market Dynamics – Trends 12. Asia-Pacific Opioid-Induced Constipation Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 12.1.1. Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.1.1.1. Peripherally restricted ?-opioid receptor antagonists 12.1.1.2. Non-selective opioid antagonists 12.1.1.3. ? -opioid receptor antagonists 12.1.1.4. Locally acting chloride channel activators 12.1.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.1.2.1. Solids 12.1.2.2. Semi-Solids 12.1.2.3. Liquids 12.1.3. Route of administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.1.3.1. Oral 12.1.3.2. Parenteral 12.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.1.4.1. Drugstore 12.1.4.2. Retail pharmacies 12.1.4.3. Hospital pharmacies 12.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.1.5.1. Japan 12.1.5.2. China 12.1.5.3. India 12.1.5.4. ASEAN 12.1.5.5. Australia & New Zealand 12.1.5.6. Rest of Asia-Pacific 12.1.6. Asia-Pacific Opioid-Induced Constipation Treatment Market - Opportunity Analysis Index, By Drug Analysis, Formulation Type, Route of Administration, Distribution Channel, and Country, 2018 – 2024 12.1.7. Europe Opioid-Induced Constipation Treatment Market Dynamics – Trends 13. Latin America Opioid-Induced Constipation Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 13.1.1. Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 13.1.1.1. Peripherally restricted ?-opioid receptor antagonists 13.1.1.2. Non-selective opioid antagonists 13.1.1.3. ? -opioid receptor antagonists 13.1.1.4. Locally acting chloride channel activators 13.1.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.1.2.1. Solids 13.1.2.2. Semi-Solids 13.1.2.3. Liquids 13.1.3. Route of administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.1.3.1. Oral 13.1.3.2. Parenteral 13.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.1.4.1. Drugstore 13.1.4.2. Retail pharmacies 13.1.4.3. Hospital pharmacies 13.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.1.5.1. Brazil 13.1.5.2. Mexico 13.1.5.3. Argentina 13.1.5.4. Venezuela 13.1.5.5. Rest of Latin America 13.1.6. Latin America Opioid-Induced Constipation Treatment Market - Opportunity Analysis Index, By Drug Analysis, Formulation Type, Route of Administration, Distribution Channel, and Country, 2018 – 2024 13.1.7. Latin America Opioid-Induced Constipation Treatment Market Dynamics – Trends 14. Middle East and Africa Opioid-Induced Constipation Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 14.1.1. Drug Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 14.1.1.1. Peripherally restricted ?-opioid receptor antagonists 14.1.1.2. Non-selective opioid antagonists 14.1.1.3. ? -opioid receptor antagonists 14.1.1.4. Locally acting chloride channel activators 14.1.2. Formulation Type Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.1.2.1. Solids 14.1.2.2. Semi-Solids 14.1.2.3. Liquids 14.1.3. Route of administration Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.1.3.1. Oral 14.1.3.2. Parenteral 14.1.4. Distribution Channel Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.1.4.1. Drugstore 14.1.4.2. Retail pharmacies 14.1.4.3. Hospital pharmacies 14.1.5. Country Analysis (2013 – 2017) and Forecast (2018 – 2024) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 14.1.5.1. Gulf Cooperation Council (GCC) Countries 14.1.5.2. Israel 14.1.5.3. South Africa 14.1.5.4. Rest of MEA 14.1.6. MEA Opioid-Induced Constipation Treatment Market - Opportunity Analysis Index, By Drug Analysis, Formulation Type, Route of Administration, Distribution Channel, and Country, 2018 – 2024 14.1.7. MEA Opioid-Induced Constipation Treatment Market Dynamics – Trends 15. Competition Landscape 15.1. Strategic Dashboard of Top Market Players 15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) 15.2.1. GlaxoSmithKline plc (U.K.) 15.2.2. AstraZeneca U.K) 15.2.3. Pfizer Inc. (U.S.) 15.2.4. SLA Pharma AG (U.K.) 15.2.5. AIKO Biotechnology, Inc. (U.S.) 15.2.6. Cubist Pharmaceuticals (Merck & Co. Inc.,) (U.S.) 15.2.7. Takeda Pharmaceutical Company Limited (Japan) 15.2.8. Boehringer Ingelheim GmbH (Germany) 15.2.9. Bayer AG (Germany) 15.2.10. Valeant (Canada) 15.2.11. Abbott Laboratories (U.S.) 15.2.12. Purdue Pharma LP (U.S.) 15.2.13. Shionogi Inc. (U.S.) 15.2.14. Cosmo Pharmaceuticals N.V. (Ireland) 16. Research Methodology 17. Key Assumptions and Acronyms
  • GlaxoSmithKline plc (U.K.)
  • AstraZeneca U.K)
  • Pfizer Inc. (U.S.)
  • SLA Pharma AG (U.K.)
  • AIKO Biotechnology, Inc. (U.S.)
  • Cubist Pharmaceuticals (Merck & Co. Inc.,) (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Boehringer Ingelheim GmbH (Germany)
  • Bayer AG (Germany)
  • Valeant (Canada)
  • Abbott Laboratories (U.S.)
  • Purdue Pharma LP (U.S.)
  • Shionogi Inc. (U.S.)
  • Cosmo Pharmaceuticals  N.V. (Ireland)